Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis.
Sciarra A, Gentilucci A, Salciccia S, Von Heland M, Ricciuti GP, Marzio V, Pierella F, Musio D, Tombolini V, Frantellizzi V, Pasquini M, Maraone A, Guandalini A, Maggi M. Sciarra A, et al. Among authors: von heland m. Urol Oncol. 2018 Jul;36(7):340.e7-340.e21. doi: 10.1016/j.urolonc.2018.03.022. Epub 2018 Apr 26. Urol Oncol. 2018. PMID: 29706458 Clinical Trial.
Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci.
Sciarra A, Panebianco V, Salciccia S, Gentilucci A, Alfarone A, Dimare L, Lisi D, Catturino S, Di Pierro G, Von Heland M, Ciccariello M, Passariello R, Gentile V. Sciarra A, et al. Among authors: von heland m. Urol Oncol. 2011 Nov-Dec;29(6):634-40. doi: 10.1016/j.urolonc.2009.07.033. Epub 2009 Nov 13. Urol Oncol. 2011. PMID: 19914107
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer.
Alfarone A, Panebianco V, Schillaci O, Salciccia S, Cattarino S, Mariotti G, Gentilucci A, Von Heland M, Passariello R, Gentile V, Sciarra A. Alfarone A, et al. Among authors: von heland m. Crit Rev Oncol Hematol. 2012 Oct;84(1):109-21. doi: 10.1016/j.critrevonc.2012.01.006. Epub 2012 Mar 7. Crit Rev Oncol Hematol. 2012. PMID: 22401991 Review.
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review.
Sciarra A, Gentilucci A, Silvestri I, Salciccia S, Cattarino S, Scarpa S, Gatto A, Frantellizzi V, Von Heland M, Ricciuti GP, Del Giudice F, Maggi M. Sciarra A, et al. Among authors: von heland m. Medicine (Baltimore). 2019 May;98(19):e15608. doi: 10.1097/MD.0000000000015608. Medicine (Baltimore). 2019. PMID: 31083254 Free PMC article.
Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients.
Lai S, Pastore S, Piloni L, Mangiulli M, Esposito Y, Pierella F, Galani A, Pintus G, Mastroluca D, Shahabadi H, Ciccariello M, Salciccia S, Von Heland M; Study Group on Geriatric Nephrology of the Italian Society of Nephrology (SIN). Lai S, et al. Among authors: von heland m. Clin Kidney J. 2018 Sep 27;12(3):414-419. doi: 10.1093/ckj/sfy085. eCollection 2019 Jun. Clin Kidney J. 2018. PMID: 31198542 Free PMC article.
Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Lai S, Mittherhofer AP, Cianci R, Riviello L, Vocaturi M, Mastroluca D, Ciccariello M, Von Heland M, Ricciuti GP, Salciccia S, Mazzaferro S. Lai S, et al. Among authors: von heland m. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2734-2743. doi: 10.26355/eurrev_201904_17546. Eur Rev Med Pharmacol Sci. 2019. PMID: 31002123 Free article.
26 results